Chemotherapy

Cancer research

Increased Risk of Myelodysplastic Syndrome and Acute Myeloid Leukemia in Ovarian Cancer Patients Treated with PARP Inhibitors

Researchers have found that ovarian cancer patients treated with first-line maintenance PARP inhibitors have a significantly higher risk of developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) compared to those treated with platinum-based chemotherapy without PARP inhibitors. The study, published in The Oncologist, analyzed data from 3,402 ovarian

Cancer research

Impact of Minimal Residual Disease on Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia

Research published in Haematologica has shed light on the impact of minimal residual disease (MRD) on the outcome of hematopoietic stem cell transplantation (HSCT) for childhood acute lymphoblastic leukemia (ALL). The study, conducted within the international phase-III FORUM trial, found that MRD positivity was associated with worse event-free survival (EFS)

Cancer

Disgraced Health Guru Hosts PS800-a-Go Seminar at Trump's Scottish Hotel Despite Banned Status in Australia

Barbara O'Neill, a 70-year-old health guru banned from practising in Australia after her teachings were found to be dangerous, is hosting a six-day PS800-a-go seminar at Trump Turnberry Hotel in Scotland. The event, which kicks off on September 22, includes 20 lectures by O'Neill and guest

Cancer

Exploring the Efficacy and Safety of New Treatment for Malignant Mesothelioma

The National Cancer Center, China, has launched a Phase 1, 2 clinical trial to investigate the effectiveness and safety of a new treatment combination for patients with malignant mesothelioma, a rare and aggressive cancer. The trial, led by principal investigator Puyuan Xing, MD, will test the combination of Iparomlimab and

Cancer

Chemotherapy-Induced Anemia Market Outlook 2032: Emerging Therapies and Global Trends

The Chemotherapy-Induced Anemia market in the seven major markets (7MM) is expected to witness significant growth, driven by the launch of emerging therapies and increasing incidence of Chemotherapy-Induced Anemia cases. In 2021, the market size exceeded USD 1 billion, with approximately 1.6 million incident cases reported. The market is

Cancer

Cancer Immunotherapy and Venous Thromboembolism: A Growing Concern

Cancer immunotherapy has shown significant promise in the treatment of various cancers, but a new study highlights a growing concern: the risk of venous thromboembolism (VTE). According to investigators at Emory University, the incidence of VTE in patients receiving immunotherapies for cancer is a significant complication, with distinct pathophysiological mechanisms

Cancer

Chris Evert's Cancer Journey: A Story of Resilience and Humility

Chris Evert, the 18-time Grand Slam winner, has been a beacon of hope and inspiration for millions of people around the world. In the last five years, she has faced her biggest challenge: battling cancer twice. Her remarkable journey is a testament to her strength, humility, and compassion. Evert'

Cancer

Devastated Mum Speaks Out After Being Forced to Choose Between Saving Her Life or Unborn Baby's

A 29-year-old mother from Middlesbrough has spoken of her heartbreak after being diagnosed with aggressive cancer while pregnant, forcing her to choose between saving her own life and her unborn baby's. Sophia Yasin was diagnosed with stage 2 pre mediastinal B-cell non-Hodgkin's lymphoma at just 15

Cancer

Breakthrough in Cancer Biomarker Detection: Researchers Enhance Sensor Sensitivity

Researchers from the University of South Brittany have made a significant advancement in the detection of cancer biomarkers using quantum resistive vapour sensors (vQRS). The team, led by Abhishek Sachan, discovered a novel approach to enhance the sensitivity of vQRS by incorporating poly(hedral oligomeric silsesquioxanes) (POSS) as nano-spacers. This

Cancer

Tislelizumab Shows Promise in Treating Gallbladder Cancer

A recent case report from Hangzhou Medical College in Hangzhou, People's Republic of China, has highlighted the potential of tislelizumab in treating advanced gallbladder cancer. The study, which was published in the journal Medicine, reported on a 70-year-old patient who experienced significant improvements in progression-free survival and overall

Cancer research

Co-targeting TGF-β and PD-L1 Enhances Chemotherapy in Triple-Negative Breast Cancer

In a groundbreaking study conducted at the University of Bourgogne in Dijon, France, researchers have uncovered a novel approach to treating triple-negative breast cancer (TNBC), one of the most aggressive and deadly forms of the disease. The study reveals that co-targeting TGF-β (transforming growth factor-beta) and PD-L1 (programmed death-ligand 1)

Cancer research

Breakthrough in Breast Cancer Treatment: New Nanoparticle Formulation Shows Promising Results

Scientists at the Institute of Medicinal Plant Development have developed a novel nanoparticle-based approach to enhance chemoimmunotherapy against 4T1 breast cancer. The research, funded by the Chinese Academy of Medical Sciences Initiative For Innovative Medicine, presents a significant advancement in cancer therapy. The new formulation, which combines squamocin with MnO2